FHI vs AB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 02, 2026

FHI

58.4
AI Score
VS
FHI Wins

AB

46.8
AI Score

Investment Advisor Scores

FHI

58score
Recommendation
HOLD

AB

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric FHI AB Winner
Forward P/E 12.0048 10.5708 AB
PEG Ratio 1.6917 0.6343 AB
Revenue Growth 18.3% -40.3% FHI
Earnings Growth 19.3% 20.9% AB
Tradestie Score 58.4/100 46.8/100 FHI
Profit Margin 21.3% 390.6% AB
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

FHI 1M: -1.3% · 3M: +9.4% AB 1M: +0.6% · 3M: +0.2%

Current Technical Phase

FHI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.8 · Price: $62.40

AB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 60

RSI (14): 60.3 · Price: $37.35

Fundamentals Snapshot

Metric FHI AB
Market Cap
Forward P/E 10.6 9.7
Trailing P/E 11.3 11.1
Revenue (TTM)
Revenue Growth 0.2% -0.4%
Gross Margin 0.7% 1.0%
Operating Margin 0.3% 1.0%
EPS 5.51 3.35
Dividend Yield 0.02% 0.09%

Frequently Asked Questions

Based on our detailed analysis, FHI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.